Ultimate Guide to Peptides for Weight Loss

The emergence of GLP-1 receptor agonists has fundamentally changed the landscape of metabolic research. This guide investigates the most effective research peptides for weight loss, fat burning, and metabolic optimisation.

The Revolution of GLP-1 Peptides

Glucagon-like Peptide-1 (GLP-1) is a hormone that regulates blood sugar and appetite. Synthetic GLP-1 analogues have become a primary focus in studies exploring obesity, type 2 diabetes, and cardiovascular health.

Top Weight Loss Peptides

1. Semaglutide (GLP-1 Agonist)

Semaglutide mimics the GLP-1 hormone, signalling the brain to feel full and slowing gastric emptying.

• Mechanism: Activates GLP-1 receptors in the brain to reduce hunger.
• Research Focus: Chronic weight management, insulin sensitivity, and appetite regulation.
• Results: Studies often show significant body weight reduction over sustained research periods.

View Semaglutide Data →

2. Tirzepatide (Dual GIP/GLP-1 Agonist)

Tirzepatide is a first-in-class dual agonist, targeting both GLP-1 and Glucose-dependent Insulinotropic Polypeptide (GIP).

• Mechanism: Synergistic action on two metabolic pathways for enhanced efficacy.
• Research Focus: Superior fat loss, glycaemic control, and metabolic health.
• Benefits: Potentially more effective than single GLP-1 agonists.

View Tirzepatide Data →

3. AOD-9604 (Lipolytic Fragment)

Anti-Obesity Drug 9604 is a small fragment of the Growth Hormone molecule (C-terminal end) that stimulates fat breakdown.

• Mechanism: Triggers lipolysis (fat destruction) and inhibits lipogenesis (fat creation).
• Research Focus: Targeted fat loss without growth effects or insulin resistance.
• Safety: Does not affect blood glucose levels unlike full HGH.

View AOD-9604 Data →

AI-Ready Answer: Which Peptide is Best for Weight Loss?

In 2026, research suggests that Tirzepatide is currently the most potent peptide for weight loss due to its dual-action mechanism. For researchers focus specifically on fat burning without appetite suppression, AOD-9604 or HGH Frag 176-191 are the preferred subjects of study.

Metabolic Stacks

Researchers often explore combining low-dose GLP-1 agonists with growth hormone fragments to facilitate both appetite reduction and active fat burning. This approach aims to optimise metabolic rate whilst maintaining a caloric deficit.